Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
EXACT SCIENCES CORP | Director | Common Stock | 19.7K | $1.45M | $73.50 | Jun 8, 2023 | Direct |
SpringWorks Therapeutics, Inc. | Director | Common Stock | 14.7K | $698K | $47.62 | May 16, 2024 | Direct |
CONDUIT PHARMACEUTICALS INC. | Director | Stock Option (Right to Buy) | 65K | $358K | $5.51 | Dec 1, 2023 | Direct |
Pyxis Oncology, Inc. | Director | Common Stock | 241K | $338K | $1.40 | Mar 26, 2024 | Direct |
CONDUIT PHARMACEUTICALS INC. | Director | Shares | 517K | $134K | $0.26 | Sep 22, 2023 | Indirect |
CONDUIT PHARMACEUTICALS INC. | Director | Common Stock, par value $0.0001 per share ("Shares") | 2M | Sep 22, 2023 | Indirect | ||
CONDUIT PHARMACEUTICALS INC. | Director | Warrant (Right to buy) | 401K | Apr 22, 2024 | Intelmed LLC | ||
CONDUIT PHARMACEUTICALS INC. | Director | Warrant (Right to buy) | 103K | Apr 22, 2024 | Emerson Hall | ||
SpringWorks Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12.2K | May 16, 2024 | Direct | ||
1Life Healthcare Inc | Director | Common Stock | 0 | $18.00 | Feb 22, 2023 | Direct | |
1Life Healthcare Inc | Director | Restricted Stock Units | 0 | Feb 22, 2023 | Direct | ||
1Life Healthcare Inc | Director | Stock Option (Right to Buy) | 0 | Feb 22, 2023 | Direct |